Acute exacerbation of usual interstitial pneumonia after resection of lung cancer - PubMed (original) (raw)
Acute exacerbation of usual interstitial pneumonia after resection of lung cancer
Hiroaki Sugiura et al. Ann Thorac Surg. 2012 Mar.
Abstract
Background: Acute exacerbation of usual interstitial pneumonia is one of the most life-threatening complications after resection of lung cancer. It is important to detect patients at high risk for acute exacerbation. The purpose of this study was to investigate the incidence of postoperative acute exacerbation and the importance of the finding of honeycombing in predicting the risk of it.
Methods: From 992 consecutive pulmonary resections for lung cancer, the background lung was retrospectively assessed histologically. Preoperative chest computed tomographic images of those patients with histologically proven usual interstitial pneumonia were retrospectively reassessed and classified into three groups: typical honeycombing, possible honeycombing, and no honeycombing. Records of patients who experienced postoperative acute exacerbation were extracted from the clinical database, and the correlation between computed tomographic findings and incidence of acute exacerbation was analyzed.
Results: Of the 992 lung cancer patients, 12 (1.2%) experienced postoperative acute exacerbation. Usual interstitial pneumonia was histologically confirmed in 249 patients, and 4.8% of them experienced postoperative acute exacerbation. No patient without usual interstitial pneumonia experienced it. Preoperative computed tomographic images were available in 205 of the 249 patients. Postoperative acute exacerbation developed in 13.6% of patients (6 of 44 patients) in the typical honeycombing group, 6.4% of patients (5 of 78 patients) in the possible honeycombing group, and 0% of patients (0 of 83 patients) in the no-honeycombing group. Compared with the no-honeycombing group, the incidence of acute exacerbation in the typical and possible honeycombing groups was significantly higher (p=0.001, p=0.025, respectively).
Conclusions: Physicians should consider the finding of possible honeycombing, as well as typical honeycombing, a potential risk factor for acute exacerbation after pulmonary resection for lung cancer.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
- Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis.
Ito H, Nakayama H, Tsuboi M, Kameda Y, Yokose T, Hasegawa C, Yamada K. Ito H, et al. Ann Thorac Surg. 2011 Mar;91(3):874-8. doi: 10.1016/j.athoracsur.2010.10.062. Ann Thorac Surg. 2011. PMID: 21353018 - Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, Fujii Y, Mitsudomi T, Yoshimura M, Maniwa T, Suzuki K, Kataoka K, Sugiyama Y, Kondo T, Date H; Japanese Association for Chest Surgery. Sato T, et al. J Thorac Cardiovasc Surg. 2014 May;147(5):1604-1611.e3. doi: 10.1016/j.jtcvs.2013.09.050. Epub 2013 Nov 20. J Thorac Cardiovasc Surg. 2014. PMID: 24267779 - Prophylaxis for acute exacerbation of interstitial pneumonia after lung resection.
Ito H, Nakayama H, Yokose T, Yamada K. Ito H, et al. Asian Cardiovasc Thorac Ann. 2014 Oct;22(8):948-54. doi: 10.1177/0218492314526187. Epub 2014 Feb 20. Asian Cardiovasc Thorac Ann. 2014. PMID: 24585320 Clinical Trial. - Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH, Moua T, Daniels CE, Hartman TE, Yi ES, Utz JP, Limper AH. Ryu JH, et al. Mayo Clin Proc. 2014 Aug;89(8):1130-42. doi: 10.1016/j.mayocp.2014.03.016. Epub 2014 May 24. Mayo Clin Proc. 2014. PMID: 24867394 Review. - Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression.
Misumi S, Lynch DA. Misumi S, et al. Proc Am Thorac Soc. 2006 Jun;3(4):307-14. doi: 10.1513/pats.200602-018TK. Proc Am Thorac Soc. 2006. PMID: 16738194 Review.
Cited by
- Lung cancer, comorbidities, and medication: the infernal trio.
Pluchart H, Chanoine S, Moro-Sibilot D, Chouaid C, Frey G, Villa J, Degano B, Giaj Levra M, Bedouch P, Toffart AC. Pluchart H, et al. Front Pharmacol. 2024 Feb 21;14:1016976. doi: 10.3389/fphar.2023.1016976. eCollection 2023. Front Pharmacol. 2024. PMID: 38450055 Free PMC article. Review. - Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
Huang C, Sun YG, Ma C, Jiao P, Wu QJ, Tian WX, Yu HB, Tong HF. Huang C, et al. J Cardiothorac Surg. 2024 Feb 8;19(1):72. doi: 10.1186/s13019-024-02508-1. J Cardiothorac Surg. 2024. PMID: 38331909 Free PMC article. - Acute exacerbation of interstitial lung disease in the intensive care unit: Principles of diagnostic evaluation and management.
Hayat Syed MK, Bruck O, Kumar A, Surani S. Hayat Syed MK, et al. World J Crit Care Med. 2023 Jun 9;12(3):153-164. doi: 10.5492/wjccm.v12.i3.153. eCollection 2023 Jun 9. World J Crit Care Med. 2023. PMID: 37397591 Free PMC article. Review. - Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
Okano N, Suefuji H, Nakajima M, Tokumaru S, Kubo N, Yoshida D, Suzuki O, Ishikawa H, Satouchi M, Nakayama H, Shioyama Y. Okano N, et al. J Radiat Res. 2023 Jun 16;64(Supplement_1):i2-i7. doi: 10.1093/jrr/rrad008. J Radiat Res. 2023. PMID: 37036751 Free PMC article. - Clinical impact of SUVmax of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection.
Akaike K, Saruwatari K, Matsushima R, Fujino K, Morinaga J, Oda S, Takahashi H, Shiraishi S, Okabayashi H, Hamada S, Tomita Y, Masunaga A, Saeki S, Ikeda K, Ichiyasu H, Suzuki M, Sakagami T. Akaike K, et al. J Thorac Dis. 2022 Oct;14(10):3801-3810. doi: 10.21037/jtd-22-604. J Thorac Dis. 2022. PMID: 36389305 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical